ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,945Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 764

$2.11M Total Retail Price of All Prescriptions

Rank: 6 out of 764

700 Patients Receiving at Least One Drug in Part D
23% Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Texas
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 700 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

3% of this provider’s 700 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$133 was the average price of a prescription from this provider, compared to $121 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Texas
ALPRAZOLAM 1,628 287 209 B 1 4
ZOLPIDEM TARTRATE 986 115 163 2 6
TRAZODONE HCL 739 124 123 3 2
CYMBALTA 675 146 113 4 9
ABILIFY 669 94 110 A 5 10
QUETIAPINE FUMARATE 640 81 92 A 6 3
DIVALPROEX SODIUM ER 622 79 94 7 14
RISPERIDONE 584 88 81 A 8 5
CLONAZEPAM 554 60 104 B 9 1
LORAZEPAM 544 117 87 B 10 12
SERTRALINE HCL 483 73 79 11 8
OLANZAPINE 458 70 53 A 12 11
MIRTAZAPINE 457 132 76 13 18
BENZTROPINE MESYLATE 441 46 61 R 14 7
ESCITALOPRAM OXALATE 386 111 67 15 16
CITALOPRAM HBR 386 92 67 15 13
FLUOXETINE HCL 380 56 59 17 15
SEROQUEL XR 369 29 59 A 18 25
BUPROPION XL 270 30 54 19 20
PRISTIQ ER 253 49 43 20 34
VENLAFAXINE HCL ER 251 36 44 21 19
DIAZEPAM 244 32 44 B 22 32
BUSPIRONE HCL 235 37 41 23 22
LAMOTRIGINE 214 22 30 24 17
LUNESTA 197 <11 35 25 54
PAROXETINE HCL 189 41 24 26 30
LITHIUM CARBONATE 187 12 27 27 21
ZIPRASIDONE HCL 183 <11 26 A 28 23
INVEGA 142 <11 22 A 29 46
TEMAZEPAM 137 42 29 B 30 35
AMPHETAMINE SALT COMBO 128 0 23 S2 31 39
SUBOXONE 121 34 14 S3 32 49
NAMENDA 115 68 20 33 24
TOPIRAMATE 109 <11 20 34 36
LATUDA 85 0 16 A 35 43
OXCARBAZEPINE 82 0 12 36 28
SAPHRIS 74 <11 25 A 37 60
CARBAMAZEPINE 74 <11 16 37 42
METHYLPHENIDATE HCL 69 0 12 S2 39 56
PROPRANOLOL HCL 68 <11 <11 40 51
DONEPEZIL HCL 64 45 14 41 33
VENLAFAXINE HCL 61 <11 <11 42 74
DOXEPIN HCL 57 <11 <11 43 45
HYDROXYZINE PAMOATE 55 16 12 R 44 37
HALOPERIDOL 51 <11 <11 A 45 31
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 4, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.